I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

VVOS Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.00%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Vivos Therapeutics Insider Trading History Chart

Vivos Therapeutics Share Price & Price History

^$2.97

▲ +0.08 (2.77%)

As of 11/21/2024 03:50 PM ET

Days: 30 | 90 | 365

This company will win the AI race

From Porter & Company | Ad

Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse.

You must read this new presentation from Porter Stansberry.

Vivos Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/20/2023	Ronald Kirk Huntsman	CEO	Buy	560	$13.25	$7,420.00	3,460
6/16/2023	Ronald Kirk Huntsman	CEO	Buy	600	$13.50	$8,100.00	2,900
6/14/2023	Ronald Kirk Huntsman	CEO	Buy	400	$12.25	$4,900.00	2,300
12/23/2022	Ronald Kirk Huntsman	CEO	Buy	800	$12.50	$10,000.00	1,900
5/31/2022	Ronald Kirk Huntsman	CEO	Buy	320	$50.75	$16,240.00	940

Trump’s Sending THIS Crypto Higher on Purpose

From Crypto 101 Media | Ad

Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…

YES, I WANT THE #1 CRYPTO NOW

SEC Filings (Institutional Ownership Changes) for Vivos Therapeutics (NASDAQ:VVOS)

26.35% of Vivos Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Vivos Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
10/24/2024	Strategic Wealth Investment Group LLC	100,000	$0.25M	0.0%	-22.4%	2.096%
2/13/2024	Armistice Capital LLC	57,000	$0.71M	0.0%	N/A	4.286%
1/16/2024	Strategic Wealth Investment Group LLC	128,789	$1.60M	0.2%	-96.0%	9.683%
4/24/2023	Strategic Wealth Investment Group LLC	3,219,705	$1.10M	0.2%	N/A	12.874%
4/20/2023	Strategic Wealth Investment Group LLC	232,737	$1.10M	0.2%	N/A	0.931%
4/18/2023	Godsey & Gibb Inc.	92,999	$32K	0.0%	N/A	0.372%
2/10/2023	Bard Associates Inc.	201,704	$81K	0.0%	-6.9%	0.806%
11/16/2022	SeaCrest Wealth Management LLC	40,000	$26K	0.0%	N/A	0.174%
11/9/2022	Boston Partners	78,454	$51K	0.0%	-36.8%	0.341%
11/4/2022	Russell Investments Group Ltd.	365,901	$0.24M	0.0%	-11.1%	1.590%
10/24/2022	Perkins Capital Management Inc.	56,500	$37K	0.0%	-65.5%	0.246%
7/29/2022	Perkins Capital Management Inc.	163,800	$0.21M	0.2%	+9.2%	0.712%
7/29/2022	Russell Investments Group Ltd.	411,589	$0.53M	0.0%	-3.1%	1.789%
5/10/2022	Boston Partners	137,354	$0.37M	0.0%	+27.2%	0.597%
5/5/2022	Russell Investments Group Ltd.	424,801	$1.14M	0.0%	+39.2%	1.846%
5/2/2022	National Asset Management Inc.	98,574	$0.27M	0.0%	+24.4%	0.428%
4/20/2022	Perkins Capital Management Inc.	150,050	$0.40M	0.3%	+10.3%	0.652%
4/12/2022	Griffin Asset Management Inc.	70,200	$0.19M	0.0%	+63.3%	0.305%
2/10/2022	Perkins Capital Management Inc.	136,050	$0.31M	0.2%	-7.1%	0.591%
2/4/2022	Boston Partners	108,015	$0.24M	0.0%	+131.5%	0.469%
2/3/2022	Cambridge Investment Research Advisors Inc.	19,200	$43K	0.0%	+60.0%	0.083%
1/28/2022	Griffin Asset Management Inc.	43,000	$97K	0.0%	-13.1%	0.187%
1/28/2022	National Asset Management Inc.	79,270	$0.18M	0.0%	+55.5%	0.344%
1/21/2022	Russell Investments Group Ltd.	305,096	$0.68M	0.0%	+554.0%	1.326%
11/16/2021	Schonfeld Strategic Advisors LLC	34,443	$0.14M	0.0%	N/A	0.151%
11/16/2021	National Asset Management Inc.	50,987	$0.21M	0.0%	+46.9%	0.224%
11/16/2021	Two Sigma Investments LP	157,324	$0.64M	0.0%	N/A	0.690%
11/12/2021	WMS Partners LLC	12,167	$49K	0.0%	-27.0%	0.053%
11/12/2021	Blueshift Asset Management LLC	18,826	$76K	0.0%	N/A	0.083%
11/9/2021	BlackRock Inc.	48,905	$0.20M	0.0%	+255.8%	0.214%
11/8/2021	Avalon Investment & Advisory	329,322	$1.33M	0.0%	+73.6%	1.444%
11/8/2021	Russell Investments Group Ltd.	46,651	$0.19M	0.0%	N/A	0.205%
11/5/2021	Boston Partners	46,651	$0.19M	0.0%	N/A	0.205%
11/2/2021	Cambridge Investment Research Advisors Inc.	12,000	$48K	0.0%	-68.0%	0.053%
10/25/2021	Perkins Capital Management Inc.	146,500	$0.59M	0.4%	-9.8%	0.642%
8/17/2021	Walleye Capital LLC	150,000	$0.74M	0.0%	N/A	0.658%
8/16/2021	WMS Partners LLC	16,667	$0.15M	0.0%	N/A	0.073%
8/16/2021	Archon Capital Management LLC	215,000	$1.06M	0.1%	N/A	0.942%
8/13/2021	Renaissance Technologies LLC	19,200	$95K	0.0%	N/A	0.084%
8/13/2021	Northern Trust Corp	11,483	$57K	0.0%	N/A	0.050%
8/13/2021	Geode Capital Management LLC	47,661	$0.24M	0.0%	+285.0%	0.209%
8/13/2021	Vanguard Group Inc.	383,891	$1.90M	0.0%	N/A	1.683%
8/12/2021	Bard Associates Inc.	215,500	$1.07M	0.3%	N/A	0.945%
8/11/2021	Millrace Asset Group Inc.	93,993	$0.47M	0.2%	N/A	0.412%
8/10/2021	National Asset Management Inc.	34,718	$0.17M	0.0%	+21.9%	0.152%
8/10/2021	Cambridge Investment Research Advisors Inc.	37,551	$0.19M	0.0%	N/A	0.165%
7/30/2021	Avalon Investment & Advisory	189,739	$0.94M	0.0%	+12.0%	0.832%
5/21/2021	Citadel Advisors LLC	15,846	$0.11M	0.0%	N/A	0.069%
5/18/2021	Millennium Management LLC	78,898	$0.52M	0.0%	-5.4%	0.346%
5/18/2021	Citadel Advisors LLC	15,846	$0.11M	0.0%	N/A	0.069%
5/14/2021	Alpha Paradigm Partners LLC	9,921	$66K	0.0%	N/A	0.054%
5/14/2021	K.J. Harrison & Partners Inc	45,419	$0.30M	0.0%	-50.3%	0.249%
5/13/2021	Avalon Investment & Advisory	169,414	$1.13M	0.0%	N/A	0.930%
5/12/2021	Geode Capital Management LLC	12,380	$82K	0.0%	N/A	0.068%
5/10/2021	Royce & Associates LP	348,000	$2.31M	0.0%	+16.0%	1.911%
5/7/2021	BlackRock Inc.	11,541	$77K	0.0%	N/A	0.063%
5/4/2021	Griffin Asset Management Inc.	59,700	$0.40M	0.1%	N/A	0.328%
2/17/2021	Jane Street Group LLC	32,237	$0.19M	0.0%	N/A	0.182%
2/16/2021	Walleye Capital LLC	74,500	$0.44M	0.0%	N/A	0.422%
2/9/2021	Perkins Capital Management Inc.	20,000	$0.12M	0.1%	N/A	0.113%
2/8/2021	Royce & Associates LP	300,000	$1.77M	0.0%	N/A	1.698%
2/8/2021	K.J. Harrison & Partners Inc	91,322	$0.54M	0.1%	N/A	0.517%

Data available starting January 2016

Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring. The company also offers VivoScore Program, a screening and home sleep test in adults and children. It markets and sells its appliances, and related treatments and services to licensed professionals, primarily general dentists in the United States and Canada. Vivos Therapeutics, Inc. was founded in 2016 and is based in Littleton, Colorado.

Today's Range

Now: $2.97

$2.80

$2.99

50 Day Range

MA: $2.78

$2.29

$4.13

52 Week Range

Now: $2.97

$1.91

$48.79

Volume

95,968 shs

Average Volume

478,085 shs

Market Capitalization

$14.37 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

7.71

Who are the company insiders with the largest holdings of Vivos Therapeutics?: Vivos Therapeutics' top insider investors include:
Ronald Kirk Huntsman (CEO)
Learn More about top insider investors at Vivos Therapeutics.
Who are the major institutional investors of Vivos Therapeutics?: Vivos Therapeutics' top institutional investors include:
Strategic Wealth Investment Group LLC — 2.10%
Learn More about top institutional investors of Vivos Therapeutics stock.
Which major investors are selling Vivos Therapeutics stock?: During the last quarter, VVOS stock was sold by these institutional investors:
Strategic Wealth Investment Group LLC